US Physical Therapy (USPH) Form 144 — 600-Share Sale via J.P. Morgan

Rhea-AI Filing Summary

US Physical Therapy Inc (USPH) Form 144 notice: The filing reports a proposed sale of 600 shares of Common stock through J.P. Morgan Securities LLC with an aggregate market value of $49,026, planned for approximately 09/11/2025 on the NYSE. The shares were acquired by vesting: 1,653 shares vested on 08/20/2025 from restricted stock grants issued between 05/16/2023 and 05/20/2025, with the acquisition characterized as payment for services rendered. The filing also discloses a prior sale of 400 shares on 06/12/2025 by Nancy Ham, generating $31,204 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Compliance Specialist

TL;DR: Routine insider sale notice showing vested restricted shares and a planned small sale on the NYSE.

The Form 144 is a procedural disclosure required when insiders propose to sell restricted or control securities under Rule 144. This filing shows 1,653 vested shares acquired on 08/20/2025 and a planned brokered sale of 600 shares via J.P. Morgan on 09/11/2025. The figures reported are modest relative to typical market capitalizations and the filing includes the required representation about lack of undisclosed material adverse information. From a compliance perspective, the form appears to provide the necessary acquisition and historical sale details.

Equity Securities Analyst

TL;DR: Disclosure indicates small insider liquidity activity; no material operational or financial signals are presented.

The notice documents a planned sale of 600 shares valued at $49,026 and a prior sale of 400 shares for $31,204. The vested shares (1,653) stem from restricted grants dating from 2023–2025 and were paid as services. These transactions are routine compensation liquidation events and, standing alone, do not provide substantive information about company performance or prospects. Impact on investors is likely neutral absent additional disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue Floor 6 New York NY 10017	600	49026	15094987	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Vesting of Restricted Stock Grants - Grants issued from 05/16/2023 through 05/20/2025)	US Physical Therapy (issuer)			1653	08/20/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nancy Ham 2705 Silver Cloud Drive Park City UT 84060	Common	06/12/2025	400	31204

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the USPH Form 144 propose to sell?

The notice proposes the sale of 600 shares of Common stock through J.P. Morgan Securities LLC, slated for approximately 09/11/2025 on the NYSE.

How were the shares being sold acquired according to the filing?

The filing states 1,653 shares vested on 08/20/2025 from restricted stock grants issued between 05/16/2023 and 05/20/2025; the consideration is listed as services rendered.

Does the filing disclose any recent sales by the seller?

Yes. It reports a prior sale of 400 shares on 06/12/2025 by Nancy Ham, which produced $31,204 in gross proceeds.

Which broker is handling the proposed sale in the Form 144?

The proposed sale is to be handled by J.P. Morgan Securities LLC, located at 390 Madison Avenue, New York, NY.

Does the Form 144 include any statement about undisclosed material information?

Yes. The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.